Jun 12, 2023 / 04:20PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody. Chris Shibutani from the Goldman research team. I'll try to behave and keep us on track here. Welcome, obviously, 44th Annual Goldman Sachs Healthcare Conference. Very pleased once again, Alkermes. Richard, it's really great to see you. Thank you for joining us. And then obviously, the team as well, Blair and Sandy, who are joining, and many people here will get a chance to discuss over the week. I have known you for a long time, many years. A lot has happened with the company in your role. We're at an interesting juncture. This is a particularly dynamic here. A lot of moving parts, opportunities in the pipeline. What's top of mind for you in terms of where you're at here in the middle of June?
Richard F. Pops - Alkermes plc - Chairman & CEO
Well, first of all, great to see you, Chris. Thanks for having us again. I think you were one of the first people when you moved to Goldman to identify what was actually changing within Alkermes and then the opportunity
Alkermes Plc at Goldman Sachs Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers